CME Group Inc. CME
264.48
(4.43)
(1.65%)
as of 25 Sep
- Market cap
- $96.5B
- P/E
- 22.3×
Follow CME
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
CME Group Inc. (CME) Net margin
CME Group Inc.'s net margin over the twelve months to 30 June 2026 was 63.1%, up 1.4 percentage points from fiscal 2025 (61.7%). Over the past ten years it has ranged from 37.5% (fiscal 2015) to 111.5% (fiscal 2017); the current reading is higher than 91% of that period. That is above the Financial Data & Stock Exchanges industry median of 23.2% and above the Financial sector median of 13.5%.
Net margin, annual
Annual
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 61.7% | 4.88 |
| FY2024 | 56.8% | (0.31) |
| FY2023 | 57.1% | 4.16 |
| FY2022 | 52.9% | (2.87) |
| FY2021 | 55.8% | 12.70 |
| FY2020 | 43.1% | (0.37) |
| FY2019 | 43.5% | (2.05) |
| FY2018 | 45.5% | (65.96) |
| FY2017 | 111.5% | 68.82 |
| FY2016 | 42.7% | 5.19 |
Quarterly
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2026 | 61.1% | (1.06) |
| Mar 2026 | 62.1% | (8.72) |
| Dec 2025 | 70.8% | 12.53 |
| Sep 2025 | 58.3% | (1.51) |
| 42 more quarters | Free account |
Against its own ten years
Low 37.5%
High 111.5%
Ten-year median
52.9%
Current reading's percentile
91
Net margin against peers
| Company | Net margin |
|---|---|
| CME CME Group Inc. | 63.1% |
| MSCI MSCI Inc compare | 40.7% |
| ICE Intercontinental Exchange Inc. compare | 38.3% |
| MCO Moody's Corporation compare | 34.3% |
| SPGI S&P Global Inc. compare | 30.5% |
| CBOE Cboe Global Markets, Inc. compare | 26.6% |
| NDAQ Nasdaq, Inc. compare | 22.5% |
| TRU TransUnion compare | 15.1% |
| COIN Coinbase Global, Inc. compare | −15.7% |
| Financial Data & Stock Exchanges industry median | 23.2% |
| Financial sector median | 13.5% |
| Market median | 0.55% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on CME
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement